5-Bromonicotinic acid
|
5-溴煙酸
|
20826-04-4
|
2-Bromo-4,5-Dimethoxybenzyl Bromide
|
2-溴-4,5-二甲氧基溴芐
|
53207-00-4
|
NITROSOISONIPECOTICACID
|
阿伐曲泊帕雜質(zhì)A 1-硝基哌啶-4-羧酸
|
6238-69-3
|
1H-Benzimidazole, 2-(1-nitroso-4-piperidinyl)-
|
阿伐曲泊帕雜質(zhì)BN1-亞硝基比拉斯汀
|
2731008-04-9
|
diethyl (4-amino-3-fluorophenyl)methylmalonate
|
氟比洛芬中間體2對(duì)照品
|
78543-08-5
|
Flurbiprofen Related Impurity 1
|
氟比洛芬中間體3對(duì)照品
|
42771-81-3
|
Flurbiprofen Related Impurity 2
|
氟比洛芬中間體4對(duì)照品
|
42771-82-4
|
diethyl (3-fluoro-4-nitrophenyl)methylmalonate
|
氟比洛芬中間體1對(duì)照品
|
78543-06-3
|
Benzoic acid, 4,4'-[(1Z)-1-oxido-1,2-diazenediyl]bis-
|
(Z)-1,2-雙(4-羧基苯基)二氮烯 1-氧化物
|
115325-88-7
|
Benzoic acid, 2-[(aminoiminomethyl)amino]-
|
2-胍基苯甲酸鹽酸鹽
|
1026613-65-9
|
2-octyldecan-1-ol
|
2-辛基癸烷-1-醇
|
45235-48-1
|
Levosimendan Impurity 1
|
左西孟旦雜質(zhì)1(二聚體雜質(zhì))
|
618458-79-0
|
Deoxycholic Impurity 15
|
脫氧膽酸雜質(zhì)15
|
570-62-7
|
Cefoperazone EP Impurity A
|
頭孢哌酮雜質(zhì)A
|
73240-08-1
|
(1S,2S,5S)-4-[2-[2-(6,6-DiMethylbicyclo[3.1.1]hept-2-yl)ethoxy]ethyl]Morpholine
|
匹維溴銨雜質(zhì)A 匹維溴銨雜質(zhì)19
|
77661-66-6
|
Pinaverium Bromide Impurity 6
|
匹維溴銨雜質(zhì)C 匹維溴銨雜質(zhì)6 HCl
|
53330-19-1
|
Morpholinium, 4-[(2-bromo-4,5-dimethoxyphenyl)methyl]-4-[2-[2-[(1S,2R,5S)-6,6-dimethylbicyclo[3.1.1]hept-2-yl]ethoxy]ethyl]-, bromide (1:1)
|
匹維溴銨雜質(zhì)3 匹維溴銨雜質(zhì)13
|
1970218-70-2
|
R-(E)]-alpha-[3-[2-(7-Chloro-2-quinolinyl)ethenyl]phenyl]-2-(1-hydroxy-1-methylethyl)benzenepropanol
|
2-[2-[3-(S)-[3-[2-(7-氯-2-喹啉基)乙烯基]苯基]-3-
羥基]丙基苯基]-2-丙醇(R-MTSM-1)
|
150026-75-8
|
Clonixin
|
N6-(1-甲乙基)賴氨酸對(duì)照品 賴氨酸雜質(zhì)5
|
17737-65-4
|
Methyl 2-amino-3-nitrobenzoate
|
2-氨基-3-硝基苯甲酸甲酯
|
57113-91-4
|
BENZOIC ACID, 2-[[(1,1-DIMETHYLETHOXY)CARBONYL]AMINO]-3-NITRO-METHYL ESTER
|
2-((叔丁氧羰基)氨基)-3-硝基苯甲酸甲酯
|
57113-90-3
|
DIMETHYL 3-NITROPHTHALATE
|
3-硝基鄰苯二甲酸甲酯
|
13365-26-9
|
2-(ETHYLSULFONYL)ETHANOL
|
2-(乙烷磺酰)乙醇
|
513-12-2
|
1-[2-(Ethylthio)ethyl]-2-Methyl-4-nitroiMidazole
|
1-[2-(乙硫基)乙基]-2-甲基-4-硝基-1H-咪唑
|
13230-19-8
|
Lecithin
|
L-alpha-卵膦脂
|
8002-43-5
|
Ilaprazole Impurity 1
|
艾普拉唑雜質(zhì)1
|
2285346-38-3
|
Ilaprazole Impurity 5
|
艾普拉唑雜質(zhì)5
|
2285346-43-0
|
Ilaprazole Impurity 7
|
艾普拉唑雜質(zhì)7
|
2285346-41-8
|
Lithium bis(trimethylsilyl)amide
|
雙(三甲基硅烷基)氨基鋰, 1.0 M
solution in THF, MKSeal
Lithium bis(trimethylsilyl)amide, 1.0 M
solution in THF, MKSea
|
4039-32-1
|
Tris(dibenzylideneacetone)dipalladium
|
三(二亞芐基丙酮)二鈀(0),
|
51364-51-3
|
2-Dicyclohexylphosphino-2'-(N,N-dimethylamino)biphenyl
|
2-二環(huán)己膦基-2'-(N,N-二
甲胺)-聯(lián)苯
|
213697-53-1
|
Azilsartan pharMaceutical interMediate
|
阿齊沙坦雜質(zhì)C5
|
136304-78-4
|
Methyl 2-oxo-3-((2'-(5-oxo-4,5-dihydro-1,2,4-oxadiazol-3-yl)biphenyl-4-yl)Methyl)-2,3-dihydro-1H-benzo[d]iMidazole-4-carboxylate
|
阿齊沙坦雜質(zhì)III-2
|
1403474-78-1
|
1-[(2'-carbaMoylbiphenyl-4-yl) Methyl]-2-ethoxybenziMidazole-7-carboxylic acid
|
阿齊沙坦雜質(zhì)1
|
1696392-11-6
|
4'-(Dibromomethyl)-[1,1'-Biphenyl]-2-Carbonitrile
|
阿齊沙坦雜質(zhì)SM02-4
|
209911-63-7
|
methyl 2-(azidocarbonyl)-3-nitrobenzoate
|
阿齊沙坦雜質(zhì)C3-3
|
856414-36-3
|
Methyl 2-[N-(tert-Butoxycarbonyl)-N-[(2'-cyanobiphenyl-4-yl)Methyl]aMino]-3-nitrobenzoate
|
阿齊沙坦雜質(zhì)SM01-9
|
139481-38-2
|
Methyl 1-[(2'-cyanobiphenyl-4-yl)methyl]-2-ethoxy-1H-benzimidazole-7-carboxylate
|
阿齊沙坦SM01
|
139481-44-0
|
(Z)-Ethyl-2-ethoxy-3-((2'-(N'-hydroxycarbaMiMidoyl) biphenyl-4-yl) Methyl)-3H-benzo[d] iMidazole-4-carboxylate
|
阿齊沙坦雜質(zhì)I-1
|
1397836-41-7
|
3-NITRO-PHTHALIC ACID 2-METHYL ESTER
|
阿齊沙坦雜質(zhì)C3-7
|
6744-85-0
|
(Z)-Methyl 2-ethoxy-3-((2'-(N'-(ethoxycarbonyloxy)carbaMiMidoyl)biphenyl-4-yl)Methyl)-3H-benzo[d]iMidazole-4-carboxylate
|
阿齊沙坦中間體II
|
147404-82-8
|
2-Ethoxy-1-[[2'-[[[(ethoxycarbonyl)oxy]amino]iminomethyl][1,1'-biphenyl]-4-yl]methyl]-1H-benzimidazole-7-carboxylic acid ethyl ester
|
阿齊沙坦雜質(zhì)II-1
|
1403474-75-8
|
Azilsartan Impurity 28
|
阿齊沙坦雜質(zhì)II-2
|
1514933-24-4
|
1,6-Naphthyridine-3-carboxylic acid, 4-(4-cyano-2-methoxyphenyl)-5-ethoxy-1,4-dihydro-2,8-dimethyl-, ethyl ester
|
非奈利酮雜質(zhì)10
|
2764833-07-8
|
4-(2-Cyanophenyl)benzyl alcohol
|
阿齊沙坦雜質(zhì)SM02-2
|
154709-19-0
|
Azilsartan Impurity 29
|
阿齊沙坦雜質(zhì)SM01-1
|
139482-04-5
|
Betamethasone Impurity 4
|
丙酸倍氯米松雜質(zhì)
|
114488-14-1
|
Ilaprazole Impurity 6
|
艾普拉唑雜質(zhì)6
|
2285346-42-9
|
1-[2-(ethylthio)ethyl]-2-methyl-5-nitro-1H-imidazole
|
1-[2-(乙硫基)乙基]-2-甲基-5-硝基-1H-咪唑
|
28795-33-7
|
Veratric acid, 6,6′-azobis-
|
(E)-6,6’-(偶氮-1,2-二基)雙(3,4-二甲氧基苯甲酸)
|
860749-26-4
|
Deoxycholic Impurity 21
|
脫氧膽酸雜質(zhì)21
|
69519-35-3
|
Deoxycholic Impurity 3
|
脫氧膽酸雜質(zhì)3
|
24637-46-5
|
Benzamide, 4-bromo-N-[[3-nitro-4-[[(tetrahydro-2H-pyran-4-yl)methyl]amino]phenyl]sulfonyl]-2-(1H-pyrrolo[2,3-b]pyridin-5-yloxy)-
|
維奈克拉雜質(zhì)3 維奈克拉雜質(zhì)4
|
2180923-65-1
|
2-Naphthalenecarbonitrile, 6-(acetyloxy)-
|
6-氰萘-2-基乙酸酯
|
860363-16-2
|
6-Quinolinecarboxamide, 4-(4-amino-3-chlorophenoxy)-3-chloro-7-methoxy-
|
樂(lè)伐替尼雜質(zhì)90
|
2023826-23-3
|
2-Naphthalenecarbonyl chloride, 6-(acetyloxy)-
|
6-(氯羰基)萘-2-乙酸酯
|
121714-82-7
|